journal article·2016-11-16Open access

Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model

Saiedeh Razi Soofiyani, Tohid Kazemi, Farzaneh Lotfipour, Akbar Mohammad hosseini, Dariush Shanehbandi, Somayeh Hallaj-Nezhadi, Behzad Baradaran

Abstract

Context Immunotherapy is among the most promising modalities for treatment of cancer. Recently, interleukin 12 (IL-12) has been used as an immunotherapeutic agent in cancer gene therapy. IL-12 can activate dendritic cells (DCs) and boost anti-tumor immune responses. Objective In the current study, we have investigated if IL-12 gene therapy can lead to the regression of tumor mass in a mouse model of fibrosarcoma. Material and methods To investigate the therapeutic efficacy of IL-12, WEHI-164 tumor cells were transfected with murine-IL12 plasmids using Lipofectamine. Enzyme linked immunosorbent assay (ELISA) was used to confirm IL-12 expression in transfected cells. The fibrosarcoma mouse model was established by subcutaneous injection of transfected cells to Balb/C mice. Mice were sacrificed and the tumors were extracted. Tumor sizes were measured by caliper. The expression of IL-12 and IFN-γ was studied with real-time PCR and western blotting. The expression of Ki-67(a tumor proliferation marker) in tumor mass was studied by immunohistochemistry staining. Results and discussion The group treated with IL-12 showed a significant decrease in tumor mass volume (P: 0.000). The results of real-time PCR and western blotting showed that IL-12 and IFN-γ expression increased in the group treated with IL-12 (relative expression of IL-12: 1.9 and relative expression of IFN-γ: 1.766). Immunohistochemistry staining showed that Ki-67 expression was reduced in the group treated with IL-12. Conclusion IL-12 gene therapy successfully led to regress of tumor mass in the fibrosarcoma mouse model. This may serve as a candidate therapeutic approach for treatment of cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · CAR-T cell therapy research · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (42)

Show source-provided references
1. Bathula SR · Burger's Medicinal Chemistry and Drug Discovery. New York: Wiley · 2010
2. 10.1021/bm801109g10.1021/bm801109g ↗
3. Bhatia S · Discov Med · 2013 · 15 · 309
4. 10.1002/ijc.2869610.1002/ijc.28696 ↗
5. 10.1084/jem.178.4.122310.1084/jem.178.4.1223 ↗
6. 10.1126/science.270.5238.908a10.1126/science.270.5238.908a ↗
7. 10.1016/S0065-2660(05)53001-310.1016/S0065-2660(05)53001-3 ↗
8. 10.1007/978-1-60327-547-7_1510.1007/978-1-60327-547-7_15 ↗
9. 10.1016/j.molonc.2012.01.00210.1016/j.molonc.2012.01.002 ↗
10. 10.1016/0008-8749(92)90011-D10.1016/0008-8749(92)90011-D ↗
11. 10.1007/s11248-005-1464-810.1007/s11248-005-1464-8 ↗
12. 10.2217/fon.13.8210.2217/fon.13.82 ↗
13. 10.1038/sj.cgt.770008310.1038/sj.cgt.7700083 ↗
14. 10.4155/tde.13.8810.4155/tde.13.88 ↗
15. 10.1084/jem.170.3.82710.1084/jem.170.3.827 ↗
16. 10.1186/1472-6890-11-310.1186/1472-6890-11-3 ↗
17. Kowalczyk DW · Acta Biochim Pol · 2003 · 50 · 61310.18388/abp.2003_3655 ↗
18. Kresina TF. · 2001
19. 10.1038/4397710.1038/43977 ↗
20. Leonard JP · Blood · 1997 · 90 · 2541
21. 10.1016/j.ymthe.2003.11.02210.1016/j.ymthe.2003.11.022 ↗
22. 10.1073/pnas.95.5.247510.1073/pnas.95.5.2475 ↗
23. 10.18433/J3TP4T10.18433/J3TP4T ↗
24. 10.1038/sj.cgt.770007210.1038/sj.cgt.7700072 ↗
25. 10.1038/sj.gt.330083410.1038/sj.gt.3300834 ↗
26. 10.1038/sj.gt.330292510.1038/sj.gt.3302925 ↗
27. 10.1172/JCI2304310.1172/JCI23043 ↗
28. 10.4049/jimmunol.166.11.694410.4049/jimmunol.166.11.6944 ↗
29. Qin Z · Cancer Res · 2003 · 63 · 4095
30. 10.1038/gt.2008.5110.1038/gt.2008.51 ↗
31. Shi X · Cancer Gene Ther · 2008 · 16 · 22710.1038/cgt.2008.82 ↗
32. 10.1016/j.jconrel.2009.10.02710.1016/j.jconrel.2009.10.027 ↗
33. 10.1161/hc1002.10522810.1161/hc1002.105228 ↗
34. 10.1089/jir.1995.15.37710.1089/jir.1995.15.377 ↗
35. 10.1038/sj.gt.330139210.1038/sj.gt.3301392 ↗
36. 10.1093/jnci/87.8.58110.1093/jnci/87.8.581 ↗
37. 10.1097/CJI.0b013e318031b55110.1097/CJI.0b013e318031b551 ↗
38. Wang JH · Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao · 2003 · 35 · 311
39. 10.2174/156652321366613112509504610.2174/1566523213666131125095046 ↗
40. 10.1002/ijc.1169610.1002/ijc.11696 ↗
41. 10.2217/imt.09.4610.2217/imt.09.46 ↗
42. 10.1002/eji.20119003510.1002/eji.201190035 ↗